Characteristics and 6-Month Outcomes in Patients with Rheumatoid Arthritis Initiating Infliximab Biosimilar IFX-dyyb in a Real-World Setting Article Swipe

PDF

Joshua F. Baker , Catherine Bakewell , Ara Dikranian , Gordon K. Lam , Jacqueline O’Brien , Page C. Moore , Miao Yu , Peter Hur , Karim R. Masri ·

YOU? · · 2024 · Open Access · · DOI: https://doi.org/10.1007/s40744-024-00653-6

Related Topics

Concepts

Medicine Biosimilar Infliximab Rheumatoid arthritis Internal medicine Rheumatology Observational study Cohort Disease

Metadata

Type: article
Language: en
Landing Page: https://doi.org/10.1007/s40744-024-00653-6
PDF: https://link.springer.com/content/pdf/10.1007/s40744-024-00653-6.pdf
OA Status: gold
Cited By: 1
References: 25
Related Works: 10
OpenAlex ID: https://openalex.org/W4392989277

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W4392989277

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.1007/s40744-024-00653-6

Digital Object Identifier
Title: Characteristics and 6-Month Outcomes in Patients with Rheumatoid Arthritis Initiating Infliximab Biosimilar IFX-dyyb in a Real-World Setting

Work title
Type: article

OpenAlex work type
Language: en

Primary language
Publication year: 2024

Year of publication
Publication date: 2024-03-20

Full publication date if available
Authors: Joshua F. Baker, Catherine Bakewell, Ara Dikranian, Gordon K. Lam, Jacqueline O’Brien, Page C. Moore, Miao Yu, Peter Hur, Karim R. Masri

List of authors in order
Landing page: https://doi.org/10.1007/s40744-024-00653-6

Publisher landing page
PDF URL: https://link.springer.com/content/pdf/10.1007/s40744-024-00653-6.pdf

Direct link to full text PDF
Open access: Yes

Whether a free full text is available
OA status: gold

Open access status per OpenAlex
OA URL: https://link.springer.com/content/pdf/10.1007/s40744-024-00653-6.pdf

Direct OA link when available
Concepts: Medicine, Biosimilar, Infliximab, Rheumatoid arthritis, Internal medicine, Rheumatology, Observational study, Cohort, Disease

Top concepts (fields/topics) attached by OpenAlex
Cited by: 1

Total citation count in OpenAlex
Citations by year (recent): 2024: 1

Per-year citation counts (last 5 years)
References (count): 25

Number of works referenced by this work
Related works (count): 10

Other works algorithmically related by OpenAlex

Full payload

id	https://openalex.org/W4392989277
doi	https://doi.org/10.1007/s40744-024-00653-6
ids.doi	https://doi.org/10.1007/s40744-024-00653-6
ids.pmid	https://pubmed.ncbi.nlm.nih.gov/38507187
ids.openalex	https://openalex.org/W4392989277
fwci	0.47868453
type	article
title	Characteristics and 6-Month Outcomes in Patients with Rheumatoid Arthritis Initiating Infliximab Biosimilar IFX-dyyb in a Real-World Setting
biblio.issue	3
biblio.volume	11
biblio.last_page	853
biblio.first_page	841
topics[0].id	https://openalex.org/T12255
topics[0].field.id	https://openalex.org/fields/24
topics[0].field.display_name	Immunology and Microbiology
topics[0].score	0.9998999834060669
topics[0].domain.id	https://openalex.org/domains/1
topics[0].domain.display_name	Life Sciences
topics[0].subfield.id	https://openalex.org/subfields/2403
topics[0].subfield.display_name	Immunology
topics[0].display_name	Biosimilars and Bioanalytical Methods
topics[1].id	https://openalex.org/T10200
topics[1].field.id	https://openalex.org/fields/27
topics[1].field.display_name	Medicine
topics[1].score	0.9940999746322632
topics[1].domain.id	https://openalex.org/domains/4
topics[1].domain.display_name	Health Sciences
topics[1].subfield.id	https://openalex.org/subfields/2745
topics[1].subfield.display_name	Rheumatology
topics[1].display_name	Rheumatoid Arthritis Research and Therapies
topics[2].id	https://openalex.org/T10038
topics[2].field.id	https://openalex.org/fields/27
topics[2].field.display_name	Medicine
topics[2].score	0.9616000056266785
topics[2].domain.id	https://openalex.org/domains/4
topics[2].domain.display_name	Health Sciences
topics[2].subfield.id	https://openalex.org/subfields/2725
topics[2].subfield.display_name	Infectious Diseases
topics[2].display_name	Tuberculosis Research and Epidemiology
funders[0].id	https://openalex.org/F4320307765
funders[0].ror	https://ror.org/01xdqrp08
funders[0].display_name	Pfizer
is_xpac	False
apc_list.value	4700
apc_list.currency	GBP
apc_list.value_usd	6850
apc_paid.value	4700
apc_paid.currency	GBP
apc_paid.value_usd	6850
concepts[0].id	https://openalex.org/C71924100
concepts[0].level	0
concepts[0].score	0.975287675857544
concepts[0].wikidata	https://www.wikidata.org/wiki/Q11190
concepts[0].display_name	Medicine
concepts[1].id	https://openalex.org/C59491497
concepts[1].level	2
concepts[1].score	0.950458288192749
concepts[1].wikidata	https://www.wikidata.org/wiki/Q864715
concepts[1].display_name	Biosimilar
concepts[2].id	https://openalex.org/C2777138892
concepts[2].level	3
concepts[2].score	0.9146681427955627
concepts[2].wikidata	https://www.wikidata.org/wiki/Q415264
concepts[2].display_name	Infliximab
concepts[3].id	https://openalex.org/C2777575956
concepts[3].level	2
concepts[3].score	0.8129816055297852
concepts[3].wikidata	https://www.wikidata.org/wiki/Q187255
concepts[3].display_name	Rheumatoid arthritis
concepts[4].id	https://openalex.org/C126322002
concepts[4].level	1
concepts[4].score	0.7012399435043335
concepts[4].wikidata	https://www.wikidata.org/wiki/Q11180
concepts[4].display_name	Internal medicine
concepts[5].id	https://openalex.org/C198451711
concepts[5].level	2
concepts[5].score	0.5373514890670776
concepts[5].wikidata	https://www.wikidata.org/wiki/Q327657
concepts[5].display_name	Rheumatology
concepts[6].id	https://openalex.org/C23131810
concepts[6].level	2
concepts[6].score	0.53311687707901
concepts[6].wikidata	https://www.wikidata.org/wiki/Q818574
concepts[6].display_name	Observational study
concepts[7].id	https://openalex.org/C72563966
concepts[7].level	2
concepts[7].score	0.4461888074874878
concepts[7].wikidata	https://www.wikidata.org/wiki/Q1303415
concepts[7].display_name	Cohort
concepts[8].id	https://openalex.org/C2779134260
concepts[8].level	2
concepts[8].score	0.2805066406726837
concepts[8].wikidata	https://www.wikidata.org/wiki/Q12136
concepts[8].display_name	Disease
keywords[0].id	https://openalex.org/keywords/medicine
keywords[0].score	0.975287675857544
keywords[0].display_name	Medicine
keywords[1].id	https://openalex.org/keywords/biosimilar
keywords[1].score	0.950458288192749
keywords[1].display_name	Biosimilar
keywords[2].id	https://openalex.org/keywords/infliximab
keywords[2].score	0.9146681427955627
keywords[2].display_name	Infliximab
keywords[3].id	https://openalex.org/keywords/rheumatoid-arthritis
keywords[3].score	0.8129816055297852
keywords[3].display_name	Rheumatoid arthritis
keywords[4].id	https://openalex.org/keywords/internal-medicine
keywords[4].score	0.7012399435043335
keywords[4].display_name	Internal medicine
keywords[5].id	https://openalex.org/keywords/rheumatology
keywords[5].score	0.5373514890670776
keywords[5].display_name	Rheumatology
keywords[6].id	https://openalex.org/keywords/observational-study
keywords[6].score	0.53311687707901
keywords[6].display_name	Observational study
keywords[7].id	https://openalex.org/keywords/cohort
keywords[7].score	0.4461888074874878
keywords[7].display_name	Cohort
keywords[8].id	https://openalex.org/keywords/disease
keywords[8].score	0.2805066406726837
keywords[8].display_name	Disease
language	en
locations[0].id	doi:10.1007/s40744-024-00653-6
locations[0].is_oa	True
locations[0].source.id	https://openalex.org/S4210196954
locations[0].source.issn	2198-6576, 2198-6584
locations[0].source.type	journal
locations[0].source.is_oa	True
locations[0].source.issn_l	2198-6576
locations[0].source.is_core	True
locations[0].source.is_in_doaj	True
locations[0].source.display_name	Rheumatology and Therapy
locations[0].source.host_organization	https://openalex.org/P4310320330
locations[0].source.host_organization_name	Adis, Springer Healthcare
locations[0].source.host_organization_lineage	https://openalex.org/P4310320330, https://openalex.org/P4310319965
locations[0].source.host_organization_lineage_names	Adis, Springer Healthcare, Springer Nature
locations[0].license	cc-by-nc
locations[0].pdf_url	https://link.springer.com/content/pdf/10.1007/s40744-024-00653-6.pdf
locations[0].version	publishedVersion
locations[0].raw_type	journal-article
locations[0].license_id	https://openalex.org/licenses/cc-by-nc
locations[0].is_accepted	True
locations[0].is_published	True
locations[0].raw_source_name	Rheumatology and Therapy
locations[0].landing_page_url	https://doi.org/10.1007/s40744-024-00653-6
locations[1].id	pmid:38507187
locations[1].is_oa	False
locations[1].source.id	https://openalex.org/S4306525036
locations[1].source.issn
locations[1].source.type	repository
locations[1].source.is_oa	False
locations[1].source.issn_l
locations[1].source.is_core	False
locations[1].source.is_in_doaj	False
locations[1].source.display_name	PubMed
locations[1].source.host_organization	https://openalex.org/I1299303238
locations[1].source.host_organization_name	National Institutes of Health
locations[1].source.host_organization_lineage	https://openalex.org/I1299303238
locations[1].license
locations[1].pdf_url
locations[1].version	publishedVersion
locations[1].raw_type
locations[1].license_id
locations[1].is_accepted	True
locations[1].is_published	True
locations[1].raw_source_name	Rheumatology and therapy
locations[1].landing_page_url	https://pubmed.ncbi.nlm.nih.gov/38507187
locations[2].id	pmh:oai:doaj.org/article:67521a50405f43d9883fc2ca5b204a32
locations[2].is_oa	False
locations[2].source.id	https://openalex.org/S4306401280
locations[2].source.issn
locations[2].source.type	repository
locations[2].source.is_oa	False
locations[2].source.issn_l
locations[2].source.is_core	False
locations[2].source.is_in_doaj	False
locations[2].source.display_name	DOAJ (DOAJ: Directory of Open Access Journals)
locations[2].source.host_organization
locations[2].source.host_organization_name
locations[2].license
locations[2].pdf_url
locations[2].version	submittedVersion
locations[2].raw_type	article
locations[2].license_id
locations[2].is_accepted	False
locations[2].is_published	False
locations[2].raw_source_name	Rheumatology and Therapy, Vol 11, Iss 3, Pp 841-853 (2024)
locations[2].landing_page_url	https://doaj.org/article/67521a50405f43d9883fc2ca5b204a32
locations[3].id	pmh:oai:pubmedcentral.nih.gov:11111629
locations[3].is_oa	True
locations[3].source.id	https://openalex.org/S2764455111
locations[3].source.issn
locations[3].source.type	repository
locations[3].source.is_oa	False
locations[3].source.issn_l
locations[3].source.is_core	False
locations[3].source.is_in_doaj	False
locations[3].source.display_name	PubMed Central
locations[3].source.host_organization	https://openalex.org/I1299303238
locations[3].source.host_organization_name	National Institutes of Health
locations[3].source.host_organization_lineage	https://openalex.org/I1299303238
locations[3].license	other-oa
locations[3].pdf_url
locations[3].version	submittedVersion
locations[3].raw_type	Text
locations[3].license_id	https://openalex.org/licenses/other-oa
locations[3].is_accepted	False
locations[3].is_published	False
locations[3].raw_source_name	Rheumatol Ther
locations[3].landing_page_url	https://www.ncbi.nlm.nih.gov/pmc/articles/11111629
indexed_in	crossref, doaj, pubmed
authorships[0].author.id	https://openalex.org/A5048537082
authorships[0].author.orcid	https://orcid.org/0000-0003-0799-7563
authorships[0].author.display_name	Joshua F. Baker
authorships[0].countries	US
authorships[0].affiliations[0].institution_ids	https://openalex.org/I2799810409
authorships[0].affiliations[0].raw_affiliation_string	Hospital of the University of Pennsylvania, Philadelphia, PA, USA
authorships[0].institutions[0].id	https://openalex.org/I2799810409
authorships[0].institutions[0].ror	https://ror.org/02917wp91
authorships[0].institutions[0].type	healthcare
authorships[0].institutions[0].lineage	https://openalex.org/I2799810409, https://openalex.org/I4210143392
authorships[0].institutions[0].country_code	US
authorships[0].institutions[0].display_name	Hospital of the University of Pennsylvania
authorships[0].author_position	first
authorships[0].raw_author_name	Joshua F. Baker
authorships[0].is_corresponding	False
authorships[0].raw_affiliation_strings	Hospital of the University of Pennsylvania, Philadelphia, PA, USA
authorships[1].author.id	https://openalex.org/A5052463347
authorships[1].author.orcid	https://orcid.org/0000-0003-2367-0640
authorships[1].author.display_name	Catherine Bakewell
authorships[1].countries	US
authorships[1].affiliations[0].institution_ids	https://openalex.org/I108785884
authorships[1].affiliations[0].raw_affiliation_string	Intermountain Healthcare, Salt Lake City, UT, USA
authorships[1].institutions[0].id	https://openalex.org/I108785884
authorships[1].institutions[0].ror	https://ror.org/04mvr1r74
authorships[1].institutions[0].type	healthcare
authorships[1].institutions[0].lineage	https://openalex.org/I108785884
authorships[1].institutions[0].country_code	US
authorships[1].institutions[0].display_name	Intermountain Healthcare
authorships[1].author_position	middle
authorships[1].raw_author_name	Catherine Bakewell
authorships[1].is_corresponding	False
authorships[1].raw_affiliation_strings	Intermountain Healthcare, Salt Lake City, UT, USA
authorships[2].author.id	https://openalex.org/A5085975901
authorships[2].author.orcid	https://orcid.org/0000-0002-2010-3272
authorships[2].author.display_name	Ara Dikranian
authorships[2].affiliations[0].raw_affiliation_string	Cabrillo Center for Rheumatic Disease, San Diego, CA, USA
authorships[2].author_position	middle
authorships[2].raw_author_name	Ara Dikranian
authorships[2].is_corresponding	False
authorships[2].raw_affiliation_strings	Cabrillo Center for Rheumatic Disease, San Diego, CA, USA
authorships[3].author.id	https://openalex.org/A5081149257
authorships[3].author.orcid
authorships[3].author.display_name	Gordon K. Lam
authorships[3].countries	US
authorships[3].affiliations[0].institution_ids	https://openalex.org/I4210143549
authorships[3].affiliations[0].raw_affiliation_string	Arthritis and Osteoporosis Consultants of the Carolinas, Charlotte, NC, USA
authorships[3].institutions[0].id	https://openalex.org/I4210143549
authorships[3].institutions[0].ror	https://ror.org/04989d402
authorships[3].institutions[0].type	other
authorships[3].institutions[0].lineage	https://openalex.org/I4210143549
authorships[3].institutions[0].country_code	US
authorships[3].institutions[0].display_name	Bone Health and Osteoporosis Foundation
authorships[3].author_position	middle
authorships[3].raw_author_name	Gordon Lam
authorships[3].is_corresponding	False
authorships[3].raw_affiliation_strings	Arthritis and Osteoporosis Consultants of the Carolinas, Charlotte, NC, USA
authorships[4].author.id	https://openalex.org/A5089484885
authorships[4].author.orcid	https://orcid.org/0009-0002-4998-5747
authorships[4].author.display_name	Jacqueline O’Brien
authorships[4].countries	US
authorships[4].affiliations[0].institution_ids	https://openalex.org/I4210129365
authorships[4].affiliations[0].raw_affiliation_string	CorEvitas, LLC, Waltham, MA, USA
authorships[4].institutions[0].id	https://openalex.org/I4210129365
authorships[4].institutions[0].ror	https://ror.org/04a6c5752
authorships[4].institutions[0].type	company
authorships[4].institutions[0].lineage	https://openalex.org/I4210129365
authorships[4].institutions[0].country_code	US
authorships[4].institutions[0].display_name	Navitas Systems (United States)
authorships[4].author_position	middle
authorships[4].raw_author_name	Jacqueline O’Brien
authorships[4].is_corresponding	False
authorships[4].raw_affiliation_strings	CorEvitas, LLC, Waltham, MA, USA
authorships[5].author.id	https://openalex.org/A5051407280
authorships[5].author.orcid	https://orcid.org/0000-0002-3428-8781
authorships[5].author.display_name	Page C. Moore
authorships[5].countries	US
authorships[5].affiliations[0].institution_ids	https://openalex.org/I4210129365
authorships[5].affiliations[0].raw_affiliation_string	CorEvitas, LLC, Waltham, MA, USA
authorships[5].institutions[0].id	https://openalex.org/I4210129365
authorships[5].institutions[0].ror	https://ror.org/04a6c5752
authorships[5].institutions[0].type	company
authorships[5].institutions[0].lineage	https://openalex.org/I4210129365
authorships[5].institutions[0].country_code	US
authorships[5].institutions[0].display_name	Navitas Systems (United States)
authorships[5].author_position	middle
authorships[5].raw_author_name	Page C. Moore
authorships[5].is_corresponding	False
authorships[5].raw_affiliation_strings	CorEvitas, LLC, Waltham, MA, USA
authorships[6].author.id	https://openalex.org/A5073319456
authorships[6].author.orcid	https://orcid.org/0000-0002-2804-6014
authorships[6].author.display_name	Miao Yu
authorships[6].countries	US
authorships[6].affiliations[0].institution_ids	https://openalex.org/I4210129365
authorships[6].affiliations[0].raw_affiliation_string	CorEvitas, LLC, Waltham, MA, USA
authorships[6].institutions[0].id	https://openalex.org/I4210129365
authorships[6].institutions[0].ror	https://ror.org/04a6c5752
authorships[6].institutions[0].type	company
authorships[6].institutions[0].lineage	https://openalex.org/I4210129365
authorships[6].institutions[0].country_code	US
authorships[6].institutions[0].display_name	Navitas Systems (United States)
authorships[6].author_position	middle
authorships[6].raw_author_name	Miao Yu
authorships[6].is_corresponding	False
authorships[6].raw_affiliation_strings	CorEvitas, LLC, Waltham, MA, USA
authorships[7].author.id	https://openalex.org/A5012501013
authorships[7].author.orcid
authorships[7].author.display_name	Peter Hur
authorships[7].countries	US
authorships[7].affiliations[0].institution_ids	https://openalex.org/I180857899
authorships[7].affiliations[0].raw_affiliation_string	Pfizer Inc, New York, NY, USA
authorships[7].institutions[0].id	https://openalex.org/I180857899
authorships[7].institutions[0].ror	https://ror.org/01xdqrp08
authorships[7].institutions[0].type	company
authorships[7].institutions[0].lineage	https://openalex.org/I180857899
authorships[7].institutions[0].country_code	US
authorships[7].institutions[0].display_name	Pfizer (United States)
authorships[7].author_position	middle
authorships[7].raw_author_name	Peter Hur
authorships[7].is_corresponding	False
authorships[7].raw_affiliation_strings	Pfizer Inc, New York, NY, USA
authorships[8].author.id	https://openalex.org/A5066631826
authorships[8].author.orcid	https://orcid.org/0000-0002-2178-9747
authorships[8].author.display_name	Karim R. Masri
authorships[8].countries	US
authorships[8].affiliations[0].institution_ids	https://openalex.org/I180857899
authorships[8].affiliations[0].raw_affiliation_string	Pfizer Inc, Collegeville, PA, 19426, USA
authorships[8].institutions[0].id	https://openalex.org/I180857899
authorships[8].institutions[0].ror	https://ror.org/01xdqrp08
authorships[8].institutions[0].type	company
authorships[8].institutions[0].lineage	https://openalex.org/I180857899
authorships[8].institutions[0].country_code	US
authorships[8].institutions[0].display_name	Pfizer (United States)
authorships[8].author_position	last
authorships[8].raw_author_name	Karim R. Masri
authorships[8].is_corresponding	True
authorships[8].raw_affiliation_strings	Pfizer Inc, Collegeville, PA, 19426, USA
has_content.pdf	True
has_content.grobid_xml	True
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://link.springer.com/content/pdf/10.1007/s40744-024-00653-6.pdf
open_access.oa_status	gold
open_access.any_repository_has_fulltext	False
created_date	2025-10-10T00:00:00
display_name	Characteristics and 6-Month Outcomes in Patients with Rheumatoid Arthritis Initiating Infliximab Biosimilar IFX-dyyb in a Real-World Setting
has_fulltext	True
is_retracted	False
updated_date	2025-11-06T03:46:38.306776
primary_topic.id	https://openalex.org/T12255
primary_topic.field.id	https://openalex.org/fields/24
primary_topic.field.display_name	Immunology and Microbiology
primary_topic.score	0.9998999834060669
primary_topic.domain.id	https://openalex.org/domains/1
primary_topic.domain.display_name	Life Sciences
primary_topic.subfield.id	https://openalex.org/subfields/2403
primary_topic.subfield.display_name	Immunology
primary_topic.display_name	Biosimilars and Bioanalytical Methods
related_works	https://openalex.org/W1993762334, https://openalex.org/W2914532353, https://openalex.org/W1981336058, https://openalex.org/W2077942718, https://openalex.org/W2774189845, https://openalex.org/W2587157414, https://openalex.org/W2924476097, https://openalex.org/W3010465489, https://openalex.org/W4390379095, https://openalex.org/W2523259317
cited_by_count	1
counts_by_year[0].year	2024
counts_by_year[0].cited_by_count	1
locations_count	4
best_oa_location.id	doi:10.1007/s40744-024-00653-6
best_oa_location.is_oa	True
best_oa_location.source.id	https://openalex.org/S4210196954
best_oa_location.source.issn	2198-6576, 2198-6584
best_oa_location.source.type	journal
best_oa_location.source.is_oa	True
best_oa_location.source.issn_l	2198-6576
best_oa_location.source.is_core	True
best_oa_location.source.is_in_doaj	True
best_oa_location.source.display_name	Rheumatology and Therapy
best_oa_location.source.host_organization	https://openalex.org/P4310320330
best_oa_location.source.host_organization_name	Adis, Springer Healthcare
best_oa_location.source.host_organization_lineage	https://openalex.org/P4310320330, https://openalex.org/P4310319965
best_oa_location.source.host_organization_lineage_names	Adis, Springer Healthcare, Springer Nature
best_oa_location.license	cc-by-nc
best_oa_location.pdf_url	https://link.springer.com/content/pdf/10.1007/s40744-024-00653-6.pdf
best_oa_location.version	publishedVersion
best_oa_location.raw_type	journal-article
best_oa_location.license_id	https://openalex.org/licenses/cc-by-nc
best_oa_location.is_accepted	True
best_oa_location.is_published	True
best_oa_location.raw_source_name	Rheumatology and Therapy
best_oa_location.landing_page_url	https://doi.org/10.1007/s40744-024-00653-6
primary_location.id	doi:10.1007/s40744-024-00653-6
primary_location.is_oa	True
primary_location.source.id	https://openalex.org/S4210196954
primary_location.source.issn	2198-6576, 2198-6584
primary_location.source.type	journal
primary_location.source.is_oa	True
primary_location.source.issn_l	2198-6576
primary_location.source.is_core	True
primary_location.source.is_in_doaj	True
primary_location.source.display_name	Rheumatology and Therapy
primary_location.source.host_organization	https://openalex.org/P4310320330
primary_location.source.host_organization_name	Adis, Springer Healthcare
primary_location.source.host_organization_lineage	https://openalex.org/P4310320330, https://openalex.org/P4310319965
primary_location.source.host_organization_lineage_names	Adis, Springer Healthcare, Springer Nature
primary_location.license	cc-by-nc
primary_location.pdf_url	https://link.springer.com/content/pdf/10.1007/s40744-024-00653-6.pdf
primary_location.version	publishedVersion
primary_location.raw_type	journal-article
primary_location.license_id	https://openalex.org/licenses/cc-by-nc
primary_location.is_accepted	True
primary_location.is_published	True
primary_location.raw_source_name	Rheumatology and Therapy
primary_location.landing_page_url	https://doi.org/10.1007/s40744-024-00653-6
publication_date	2024-03-20
publication_year	2024
referenced_works	https://openalex.org/W2319957449, https://openalex.org/W2613299853, https://openalex.org/W2120393706, https://openalex.org/W4231972505, https://openalex.org/W2622706118, https://openalex.org/W2793124769, https://openalex.org/W2985442862, https://openalex.org/W3018053945, https://openalex.org/W2314763045, https://openalex.org/W2162768160, https://openalex.org/W2259088801, https://openalex.org/W4221019027, https://openalex.org/W4241784418, https://openalex.org/W3206147259, https://openalex.org/W2972331309, https://openalex.org/W2795715927, https://openalex.org/W2465264340, https://openalex.org/W2086478005, https://openalex.org/W2117231045, https://openalex.org/W2342464058, https://openalex.org/W4309822138, https://openalex.org/W3027356957, https://openalex.org/W4223415262, https://openalex.org/W4386571444, https://openalex.org/W2762105939
referenced_works_count	25
abstract_inverted_index
cited_by_percentile_year.max	94
cited_by_percentile_year.min	90
corresponding_author_ids	https://openalex.org/A5066631826
countries_distinct_count	1
institutions_distinct_count	9
corresponding_institution_ids	https://openalex.org/I180857899
sustainable_development_goals[0].id	https://metadata.un.org/sdg/3
sustainable_development_goals[0].score	0.5799999833106995
sustainable_development_goals[0].display_name	Good health and well-being
citation_normalized_percentile.value	0.56748838
citation_normalized_percentile.is_in_top_1_percent	False
citation_normalized_percentile.is_in_top_10_percent	False